Biostax Corp (BTAX)

[locicat1]

Thank you for your response. Appears that when you said removed you were referring to his name and all the attendant information about him being removed from the Cytocom website. In this case it isn't just bad PR and little or no communication. I strongly believe an SEC 8-K should have been made-at least stating at the very minimum he was no longer with the Cytocom. Why?? Because the 8-K filing of March 28, 2018 covering the purported receipt of Minutes From FDA Meeting for Lodonal for the Treatment for Crohn's Disease announcement came from IMUN and the wording in the announcement contained several clearly direct tie ins between IMUN and Cytocom. And Cytocom CEO Abeles was quoted with significant statements regarding the outcome of the January 16, 2018 FDA Meeting. What happened? Where is he? Not only more obfuscation, but required SEC filing negligence.